Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed with IBI354 (HER2 Monoclonal Antibody-Camptothecin Derivative Conjugate, HER2 ADC) in a randomized, controlled, multicenter […]

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial approval from the U.S. Food and Drug Administration (FDA). As of now, AIM has obtained FDA approval to begin clinical trials for two major mRNA vaccine

CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I products) issuer in Hong Kong, is proud to announce the listing of Asia's first batch of 9 single stock L&I products on Hong Kong Stock Exchange (HKEX) on 24th March 2025, providing investors with convenient trading or hedging tools for popular US stocks

CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I products) issuer in Hong Kong,is proud to announce the listing of Asia'sfirst batch of 9 single stock L&I products on Hong Kong Stock Exchange (HKEX) on 24th March 2025, providing investors with convenient trading or hedging tools for popular US stocks during Asia

U.S.IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform — Evaluation of SCB-1019 as part of a respiratory combinationTrimer-Tagged PreF vaccine (RSV + hMPV ± PIV3) is also on track for clinical trial initiation in 2025 — Clover Biopharmaceuticals, Ltd.(Clover; HKEX: 02197), a

— EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. — Preclinical highlights: — EVM14 induced a dose-dependent, antigen-specific immune response in mice and significantly inhibited tumor growth in multiplesyngeneic tumor models. — As a

— 24-Year-Old Zoi Sadowski-Synnott from New Zealand Earns Victory in Women's Snowboard Slopestyle, Claims World Championship Title for Third Time — 20-Year-Old Kokomo Murase from Japan Takes 2nd Place in Women's Snowboard Slopestyle — 24-Year-Old Birk Ruud from Oslo, Norway, Wins World Championship in Men's Freeski Slopestyle for 2nd Time, 26-Year-Old Alex Hall from Park

(NYSE:VG), RADNOR, Pa., March 23, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Venture Global, Inc. (“Venture”) (NYSE: VG) on behalf of those

(NYSE:FNA),(NasdaqGM:AVTE),(NASDAQ:RSLS), NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Paragon 28, Inc. (NYSE: FNA)'s sale to Zimmer Biomet Holdings, Inc. for $13.00 per share in

PLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION NEW YORK and CHICAGO, March 23, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP, a preeminent national consumer rights law firm, is investigating claims on behalf of people who have been impacted by the Lafayette Federal Credit Union (“LFCU”) data breach. LFCU maintains its headquarters in